Adverum Biotechnologies, Inc. Gains 34.51%
Mon, Feb 05, 2024 at 07:32 PM
Adverum Biotechnologies, Inc. (ADVM:NASDAQ) soared at $1.91, a gain of 34.5%. On Mon, Feb 05, 2024, ADVM:NASDAQ touched a New 2-Week High of $1.91. The stock got featured on our News Catalysts scanner on Mon, Feb 05, 2024 at 10:05 AM in the 'BIOTECH' category. From Mon, Jan 22, 2024, the stock recorded 60.00% Up Days and 63.64% Green Days
About Adverum Biotechnologies, Inc. (ADVM:NASDAQ)
Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.
Top 10 Gainers:
- Gorilla Technology Group Inc. (GRRR:NASDAQ), 96.36%
- 4D Molecular Therapeutics Inc. (FDMT:NASDAQ), 84.62%
- USD Partners LP (USDP:NYSE), 72.47%
- MorphoSys AG (MOR:NASDAQ), 56.01%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 52.57%
- MIRA Pharmaceuticals Inc. (MIRA:NASDAQ), 45.99%
- Selina Hospitality PLC (SLNA:NASDAQ), 43.79%
- Warrantee Inc. (WRNT:NASDAQ), 40.64%
- Jianpu Technology Inc. (JT:NYSE), 34.67%
- Adverum Biotechnologies, Inc. (ADVM:NASDAQ), 34.51%